Search Results
Jul 29, 2026, 03:00 ET AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Severe Alopecia Areata
2010;62(2):177-188, quiz 189-190. doi:10.1016/j.jaad.2009.10.032Pratt CH, King LE, Messenger AG, Christiano AM, Sundberg JP. Alopecia areata. Nat Rev Dis Primers. 2017;3(1):17011. doi:10.1038/nrdp.2017.11Davey L, Clarke V, Jenkinson E. Living with alopecia areata: an online qualitative survey
More news about: AbbVie
Jul 24, 2026, 08:30 ET Roche receives FDA clearance for the cobas® BV/CV assay, enabling fast and highly accurate vaginitis diagnosis
High global burden and costs of bacterial vaginosis: A systematic review and meta-analysis. Sex Transm Dis. May 2019; 46(5): 304-311. doi: 10.1097/OLQ.0000000000000972. PMID: 30624309.
More news about: Roche
Jul 23, 2026, 03:33 ET Lundbeck receives FDA Fast Track designation for Lu AH69593, an investigational orexin 2 receptor agonist for narcolepsy
aetiopathophysiology, diagnosis and treatment. Nat Rev Neurol. 2019;15:519–539.Kornum BR, Knudsen S, Ollila HM, et al. Narcolepsy. Nat Rev Dis Primers. 2017;3:16100.Black J, Reaven NL, Funk SE, et al. The Burden of Narcolepsy Disease (BOND) study: health-care utilization and cost
More news about: H. Lundbeck A/S
Jul 23, 2026, 03:29 ET Lundbeck receives FDA Fast Track designation for Lu AH69593, an investigational orexin 2 receptor agonist for narcolepsy
aetiopathophysiology, diagnosis and treatment. Nat Rev Neurol. 2019;15:519–539.Kornum BR, Knudsen S, Ollila HM, et al. Narcolepsy. Nat Rev Dis Primers. 2017;3:16100.Black J, Reaven NL, Funk SE, et al. The Burden of Narcolepsy Disease (BOND) study: health-care utilization and cost
More news about: H. Lundbeck A/S
Jul 21, 2026, 22:00 ET Vắc xin phòng sốt xuất huyết Dengue của Takeda (TAK-003) trở thành vắc xin phòng sốt xuất huyết đầu tiên được phê duyệt tại Ấn Độ, mang đến giải pháp phòng ngừa tại một trong những quốc gia có nguy cơ cao nhất thế giới
Huang CY-H và cộng sự. Genetic and phenotypic characterization of manufacturing seeds for tetravalent dengue vaccine (DENVax). PLoS Negl Trop Dis. 2013;7:e2243.
More news about: Takeda
Jul 21, 2026, 07:00 ET Alebund Pharmaceuticals Announces First Participant Randomized and Dosed in Global Phase IIb Multi-Regional Clinical Trial of AP306 for Hyperphosphatemia
Suppl. 2017;7(1):1–59.[2] Block GA, et al. J Am Soc Nephrol. 2004;15(8):2208–2218.[3] Tentori F, et al. Am J Kidney Dis. 2008;52(3):519–530.[4] CIC, Global and Chinese Hyperphosphatemia Drug Industry Blue Book, 2023.[5] Guedes M, et al. Kidney
More news about: Alebund Pharmaceuticals
Jul 20, 2026, 03:46 ET Lundbeck announces last patient randomized in DEEp OCEAN, a large Phase III trial in developmental and epileptic encephalopathies (DEEs)
LinkedIn.ReferencesScheffer IE, et al. Epilepsia. 2025;00:1-10Scheffer IE et al. Nat Rev Dis Primers 2024;10:61Ren A, et al. J Medicinal Chem. 2025;68(11):10599-10618
More news about: H. Lundbeck A/S
Jul 20, 2026, 03:42 ET Lundbeck announces last patient randomized in DEEp OCEAN, a large Phase III trial in developmental and epileptic encephalopathies (DEEs)
LinkedIn.ReferencesScheffer IE, et al. Epilepsia. 2025;00:1-10Scheffer IE et al. Nat Rev Dis Primers 2024;10:61Ren A, et al. J Medicinal Chem. 2025;68(11):10599-10618
More news about: H. Lundbeck A/S
Jul 17, 2026, 01:25 ET Camurus' NDA resubmission for CAM2029 in acromegaly accepted for review by the US FDA
Global epidemiology of acromegaly: a systematic review and meta-analysis. Eur J Endocrinology. 2021; 185:251-63.Colao A., et al. Acromegaly. Nat Rev Dis Primers. 2019;5(1):20.
More news about: Camurus AB
Jul 17, 2026, 01:22 ET Camurus' NDA resubmission for CAM2029 in acromegaly accepted for review by the US FDA
Global epidemiology of acromegaly: a systematic review and meta-analysis. Eur J Endocrinology. 2021; 185:251-63.Colao A., et al. Acromegaly. Nat Rev Dis Primers. 2019;5(1):20.
More news about: Camurus AB
Jul 13, 2026, 07:30 ET Keenova Announces Publication of New Acthar® Gel (repository corticotropin injection) Manuscript in the Journal of Comparative Effectiveness Research
CA, et al. Estimating the prevalence of polymyositis and dermatomyositis from administrative data: age, sex and regional differences. Ann Rheum Dis. 2009;68(7):1192-1196.
More news about: Keenova Therapeutics
Jul 09, 2026, 13:16 ET /C O R R E C T I O N -- Eli Lilly and Company/
Prediction of Cognitive and Functional Decline in Unimpaired Older Individuals: Longitudinal Data from the A4 and LEARN Studies. J Prev Alzheimers Dis. 2024;11(4):802–813. Alzheimer's Association. Stages of Alzheimer's.
More news about: Eli Lilly and Company
Jul 08, 2026, 05:03 ET Grünenthal receives FDA Orphan Drug and Rare Pediatric Disease Designations for Tegacorat for the Treatment of Duchenne Muscular Dystrophy
[email protected][1] Crisafulli S, et al. Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis. Orphanet J Rare Dis. 2020; 15(1):141.[2] Bez Batti Angulski A, et al. Duchenne muscular dystrophy: disease mechanism and therapeutic strategies. Front Physiol. 2023;
More news about: Grünenthal Group
Jul 01, 2026, 22:00 ET 越來越多年輕人受落髮困擾：REGAINE®*落建引領毛髮科學研究發展
[8] Hussein, RS, et.al, Applications and efficacy of minoxidil in dermatology. Skin Health Dis. 2024 Nov 24;4(6):e472. doi: 10.1002/ski2.472. PMCID: PMC11608877 PMID: 39624749.
More news about: REGAINE®
Jul 01, 2026, 22:00 ET 越來越多年輕人受脫髮困擾：REGAINE®*培健引領毛髮科學研究發展
[8] Hussein, RS, et.al, Applications and efficacy of minoxidil in dermatology. Skin Health Dis. 2024 Nov 24;4(6):e472. doi: 10.1002/ski2.472. PMCID: PMC11608877 PMID: 39624749.
More news about: REGAINE®
Jun 29, 2026, 03:10 ET AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Severe Alopecia Areata
Acad Dermatol. 2010;62(2):177-188, quiz 189-190.Pratt CH, King LE, Messenger AG, Christiano AM, Sundberg JP. Alopecia areata. Nat Rev Dis Primers. 2017;3(1):17011Davey L, Clarke V, Jenkinson E. Living with alopecia areata: an online qualitative survey study. Br J Dermatol.
More news about: AbbVie
Jun 29, 2026, 03:10 ET AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Severe Alopecia Areata
Acad Dermatol. 2010;62(2):177-188, quiz 189-190.Pratt CH, King LE, Messenger AG, Christiano AM, Sundberg JP. Alopecia areata. Nat Rev Dis Primers. 2017;3(1):17011Davey L, Clarke V, Jenkinson E. Living with alopecia areata: an online qualitative survey study. Br J Dermatol.
More news about: AbbVie
Jun 26, 2026, 12:35 ET Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis
Curr Opin Neurol. 2010 Oct;23(5):536-40.21 Finnis MF, Jayawant S. Juvenile myasthenia gravis: a paediatric perspective. Autoimmune Dis. 2011; 2011:404101.22 Haliloglu G, et al. Gender prevalence in childhood multiple sclerosis and myasthenia gravis. J Child Neurol.
More news about: Johnson & Johnson
Jun 24, 2026, 09:00 ET Metabolon Delivers Large-Scale Metabolomics Dataset to Genomics England's 100,000 Genomes Project to Advance Rare Disease Research
L., et al., Information needs of physicians regarding the diagnosis of rare diseases: a questionnaire-based study in Belgium. Orphanet J Rare Dis, 2019. 14(1): p. 99.Liu, N., et al., Comparison of Untargeted Metabolomic Profiling vs Traditional Metabolic Screening to Identify
More news about: Metabolon, Inc.
Jun 24, 2026, 09:00 ET Metabolon Delivers Large-Scale Metabolomics Dataset to Genomics England's 100,000 Genomes Project to Advance Rare Disease Research
L., et al., Information needs of physicians regarding the diagnosis of rare diseases: a questionnaire-based study in Belgium. Orphanet J Rare Dis, 2019. 14(1): p. 99.Liu, N., et al., Comparison of Untargeted Metabolomic Profiling vs Traditional Metabolic Screening to Identify
More news about: Metabolon, Inc.
Jun 24, 2026, 09:00 ET MUG® Root Beer and Yung Gravy Release "Float Float Baby" Remix Track to Celebrate New MUG Root Beer Floats Vanilla Howler™
new Mug Floats Vanilla Howler is to put a Gravy-spin on a 90's classic just in time to 'Float Float Baby' with the whole fam, all summer long.""Dis track got da whole pack barkin'. Big beats. Big sips. Float szn officially goin crazy," said MUG mascot, Dog.Fans can follow @MugRootBeer on
More news about: PepsiCo Beverages North America
Jun 23, 2026, 08:55 ET NYSE Content Update: FIRY Announces Rebranding From Skillz Inc.
June 23rdTraders monitor new developments across the AI trade and the conflict in the Middle East.Disney (NYSE: DIS) releases the result of its latest 'Generation Stream' study at Cannes Lions:84% of streamers say they feel streaming is the
More news about: New York Stock Exchange
Jun 23, 2026, 05:00 ET AbbVie Announces European Commission Approval of MAVIRET® (Glecaprevir/Pibrentasvir) for People with Acute Hepatitis C Virus Infection
Comprehensive Review of Clinical and Economic Evidence". Infect Dis Ther. 2017 Jun;6(2):297-301.4 De Oliveria Andrade LJ., et al. Association between hepatitis C and hepatocellular carcinoma. J Glob Infect Dis. 2009 Jan;1(1):33-7.5 MAVIRET® Summary
More news about: AbbVie
Jun 18, 2026, 08:59 ET MONDRIAN CANCUN INAUGURA UNA NUEVA ETAPA PARA LA MARCA CON SU PRIMER CONCEPTO TODO INCLUIDO
Dis-loyalty la innovadora membresía global de viajaes y gastronomía de Ennismore, y disfrute de un 50% de descuento en su primera estancia para viajes del
More news about: Ennismore
Jun 18, 2026, 08:42 ET MONDRIAN DEBUTS FIRST-EVER ALL-INCLUSIVE EXPERIENCE WITH MONDRIAN CANCUN
Dis-loyalty, our game-changing global travel and food membership, and take 50% off your first stay from August 19 to December 20.For
More news about: Ennismore